Wei Eric Wang

1.8k total citations
46 papers, 1.3k citations indexed

About

Wei Eric Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Wei Eric Wang has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 18 papers in Cardiology and Cardiovascular Medicine and 11 papers in Surgery. Recurrent topics in Wei Eric Wang's work include Congenital heart defects research (11 papers), Cardiac Fibrosis and Remodeling (8 papers) and Signaling Pathways in Disease (6 papers). Wei Eric Wang is often cited by papers focused on Congenital heart defects research (11 papers), Cardiac Fibrosis and Remodeling (8 papers) and Signaling Pathways in Disease (6 papers). Wei Eric Wang collaborates with scholars based in China, United States and Thailand. Wei Eric Wang's co-authors include Chunyu Zeng, Qiao Liao, Dezhong Yang, Wenbin Fu, Xiongwen Chen, Liangpeng Li, Xuewei Xia, Caiyu Chen, Rongchuan Yue and Xiaoli Yang and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Wei Eric Wang

45 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Eric Wang China 19 813 335 281 224 149 46 1.3k
Lina Kang China 21 673 0.8× 355 1.1× 281 1.0× 203 0.9× 115 0.8× 54 1.4k
Randolph S. Faustino United States 20 1.3k 1.6× 200 0.6× 432 1.5× 160 0.7× 118 0.8× 47 1.7k
Xiaowei Wang China 20 528 0.6× 281 0.8× 258 0.9× 174 0.8× 118 0.8× 70 1.4k
Bao-Wei Wang Taiwan 25 845 1.0× 268 0.8× 249 0.9× 393 1.8× 121 0.8× 47 1.6k
Wei-Jan Chen Taiwan 25 581 0.7× 631 1.9× 179 0.6× 255 1.1× 82 0.6× 55 1.7k
Nathalie Mougenot France 26 948 1.2× 683 2.0× 223 0.8× 154 0.7× 164 1.1× 70 1.8k
Norifumi Urao United States 26 1.1k 1.4× 218 0.7× 301 1.1× 240 1.1× 324 2.2× 49 2.3k
Qiu‐Xiong Lin China 22 1.1k 1.3× 430 1.3× 239 0.9× 668 3.0× 71 0.5× 61 1.8k
Tao Tan United States 25 1.1k 1.4× 168 0.5× 190 0.7× 293 1.3× 329 2.2× 58 1.8k
Xian Jin China 14 569 0.7× 159 0.5× 148 0.5× 229 1.0× 109 0.7× 31 1.1k

Countries citing papers authored by Wei Eric Wang

Since Specialization
Citations

This map shows the geographic impact of Wei Eric Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Eric Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Eric Wang more than expected).

Fields of papers citing papers by Wei Eric Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Eric Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Eric Wang. The network helps show where Wei Eric Wang may publish in the future.

Co-authorship network of co-authors of Wei Eric Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Eric Wang. A scholar is included among the top collaborators of Wei Eric Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Eric Wang. Wei Eric Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Lixin, Bingjun Lu, Dongdong Sun, et al.. (2025). Cathepsin K as a key regulator of myocardial fibrosis in dilated cardiomyopathy and a promising therapeutic target. Journal of Biological Chemistry. 301(8). 110421–110421.
2.
Zhuang, Ping, Jianzhou Zou, Xiaokang Chen, et al.. (2024). A meta-analysis and systematic review of myocardial infarction-induced cardiomyocyte proliferation in adult mouse heart. BMC Medicine. 22(1). 603–603. 1 indexed citations
4.
Liu, Lingyan, et al.. (2024). Metabolic Reprogramming: A Byproduct or a Driver of Cardiomyocyte Proliferation?. Circulation. 149(20). 1598–1610. 26 indexed citations
5.
Yang, Xinyue, Liangpeng Li, Chunyu Zeng, & Wei Eric Wang. (2023). The characteristics of proliferative cardiomyocytes in mammals. Journal of Molecular and Cellular Cardiology. 185. 50–64. 5 indexed citations
6.
Qu, Shuang, Cheng Yu, Yue Chen, et al.. (2022). LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis. SHILAP Revista de lepidopterología. 22(5). 772–783. 6 indexed citations
7.
Wu, Hao, Xuemei Wang, Xiaokang Chen, et al.. (2022). Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling. Acta Pharmacologica Sinica. 44(6). 1149–1160. 14 indexed citations
8.
Li, Liangpeng, Wenbin Fu, Xue Gong, et al.. (2020). The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction. European Heart Journal. 42(14). 1415–1430. 32 indexed citations
9.
Fu, Wenbin, Qiao Liao, Liangpeng Li, et al.. (2020). An Aurora Kinase B–Based Mouse System to Efficiently Identify and Analyze Proliferating Cardiomyocytes. Frontiers in Cell and Developmental Biology. 8. 570252–570252. 10 indexed citations
10.
Yang, Jining, Xiaoying Zhang, Long Yi, et al.. (2019). Hepatic PKA inhibition accelerates the lipid accumulation in liver. Nutrition & Metabolism. 16(1). 69–69. 15 indexed citations
11.
Jiang, Jiahui, Cong Lan, Liangpeng Li, et al.. (2018). A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(10). 3459–3467. 41 indexed citations
12.
Yue, Rongchuan, Wenbin Fu, Cong Lan, et al.. (2017). Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction. Stem Cell Research & Therapy. 8(1). 17–17. 10 indexed citations
13.
Zheng, Shuo, et al.. (2017). Activation of angiotensin II type 1 receptors increases D4 dopamine receptor expression in rat renal proximal tubule cells. Hypertension Research. 40(7). 652–657. 8 indexed citations
14.
Fu, Jinjuan, Xue Zou, Yu Han, et al.. (2016). Tirofiban induces vasorelaxation of the coronary artery via an endothelium-dependent NO-cGMP signaling by activating the PI3K/Akt/eNOS pathway. Biochemical and Biophysical Research Communications. 474(3). 599–605. 14 indexed citations
15.
Yao, Yong‐Gang, Wei Wang, Meixiang Li, et al.. (2016). Curcumin Exerts its Anti-hypertensive Effect by Down-regulating the AT1 Receptor in Vascular Smooth Muscle Cells. Scientific Reports. 6(1). 25579–25579. 60 indexed citations
16.
Shi, Weibin, Hao Luo, Zhen Wang, et al.. (2015). Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells. Hypertension Research. 38(12). 807–812. 8 indexed citations
17.
Wang, Wei Eric, Dezhong Yang, Liangpeng Li, et al.. (2014). GW25-e5273 Manipulating PHD2 to Promote the Therapeutic Effect of Stem Cell Transplantation for Myocardial Infarction. Journal of the American College of Cardiology. 64(16). C12–C13. 1 indexed citations
18.
Yu, Changqing, Zhen Wang, Yu Han, et al.. (2014). Dopamine D4 receptors inhibit proliferation and migration of vascular smooth muscle cells induced by insulin via down-regulation of insulin receptor expression. Cardiovascular Diabetology. 13(1). 97–97. 24 indexed citations
19.
Zhao, Yang, Wei Eric Wang, & Qian Zhang. (2013). CIAPIN1 siRNA Inhibits Proliferation, Migration and Promotes Apoptosis of VSMCs by Regulating Bcl-2 and Bax. Current Neurovascular Research. 10(1). 4–10. 18 indexed citations
20.
Wang, Wei Eric, Hongyong Wang, Xukai Wang, & Chunyu Zeng. (2013). A transition of P2Y12 antagonists for acute coronary syndrome: benefits, risks and costs. Journal of Thrombosis and Thrombolysis. 37(2). 102–106. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026